Industry sponsored sessions
Change does not mean stagnation
- New format does not mean you should lose out on crucial knowledge.
- Top experts in the field will be reviewing recent trials and findings which will shape the future of clinical practice.
- Stay up to speed with the latest data on HIV developments and innovative solutions.
11:00 – 12:00, room CAPITAL SUITE 14
Industry Sponsored Session – Virology Education
Immune Non-Responders: A Remaining Unmet Need
Chair: Anton Pozniak (United Kingdom), Jonathan Schapiro (Israel)
|
Introduction Anton Pozniak (United Kingdom) |
11:00 - 11:05 |
|
Mechanisms of poor immune reconstitution in HIV patients Peter Hunt (USA) |
11:05 - 11:20 |
|
Potential role of specific drugs in immune reconstitution Walther Mothes (USA) |
11:20 - 11:35 |
|
CD4 responses in trials of highly treatment experienced patients Antonella Castagna (Italy) |
11:35 - 11:50 |
|
Discussion, Q&A, Closure |
11:50 - 12:00 |
12:30 – 13:30, room CAPITAL SUITE 14
Industry Sponsored Session– Janssen
Learning outcomes: HIV and SARS-CoV-2: Two entangled epidemics
Chair: Esteban Martinez (Spain)
|
Welcome and introduction Esteban Martinez (Spain) |
12:30 - 12:35 |
|
Expert Insights presentation: Impact of COVID-19 on 90-90-90-90: Perspective from Lombardy region Silvia Nozza (Italy) |
12:35 – 12:45 |
|
Expert Insights presentation: COVID-19 as an opportunity for the `new normal' Karine Lacombe (France) |
12:45 – 12:55 |
|
Patient Insights presentation: Experiences of living with HIV during the pandemic Mario Cascio (Italy) |
12:55 – 13:05 |
|
Panel discussion: What learnings can we take from COVID-19 to inform the future management of people living with HIV? All |
13:05 – 13:25 |
|
Summary and close Esteban Martinez (Spain) |
13:25 - 13:30 |
13:30 - 15:00, room HALL S11
Industry Sponsored Session– MSD
Forty years later… Where are we now in the HIV Journey?
Chair: Anton Pozniak (United Kingdom)
|
Opening / Welcome Anton Pozniak (United Kingdom) |
13:30 – 13:35 |
|
Are we there yet? Jürgen Rockstroh (Germany) |
13:35 - 13:50 |
|
Practical considerations about metabolic issues in PLWH Jordan Lake (USA) |
13:50 - 14:05 |
|
Leaving no one behind Andrew Ustianowsky (United Kingdom) |
14:05 - 14:20 |
|
Individualization of treatment: Living Well with HIV (Case Discussion) Ana Milinkovic (United Kingdom) |
14:20 - 14:40 |
| Panel Discussion and Q&A | 14:40 - 15:00 |
14:00 - 15:30, room CAPITAL SUITE 14
Industry Sponsored Session – Gilead
(organized by Clinical Care Options)
Individualized Choices in Antiretroviral Therapy: Present and Future
Chair: Chloe Orkin (United Kingdom)
|
Overview of Current Patient-Centered ART Chloe Orkin (United Kingdom) |
14:00 – 14:15 |
|
Case-Based Discussion: Putting Individualized Care Into Practice
|
14:15 - 15:00 |
|
Future ART: Closing the Remaining Gaps Jean-Michel Molina (France) |
15:00 - 15:10 |
| Question and Answers | 15:10 - 15:30 |
16:15 - 17:15, room CAPITAL SUITE 12
Industry Sponsored Session – Thera Technologies
Taking a new approach:
Therapeutic options for highly treatment-experienced HIV-1 patients
Chair: Graeme Moyle (United Kingdom)
|
Welcome and introductions Graeme Moyle (United Kingdom) |
16:15 - 16:20 |
|
Understanding the challenges of highly treatment-experienced HIV-1 patients Antonella Castagna (Italy) |
16:20 -16:35 |
|
A virologist’s perspective on management Anne-Geneviève Marcelin (France) |
16:35 - 16:50 |
|
Building an optimised regimen: The impact of drug-drug interactions David Back (United Kingdom) |
16:50 - 17:05 |
|
Discussion and Q&A All faculty, Q&A facilitated by Graeme Moyle (United Kingdom) |
17:05 - 17:15 |
07:30 - 08:30, room HALL S11
Industry Sponsored Session – MSD
Forging new paths together to address unmet needs in HIV
Chair: Ian Hodgson (United Kingdom)
|
Opening/Welcome Ian Hodgson (United Kingdom) |
07:30 -07:40 |
|
Lessons to learn from the COVID-19 pandemic
|
07:40 - 08:00 |
|
Successful collaboration in HIV (presentation)
|
08:00 -08:10 |
|
Advancing policy change
|
08:10 - 08:25 |
|
Closing Ian Hodgson (United Kingdom) |
08:25 - 08:30 |
12:00 - 13:00, room HALL S11
Industry Sponsored Session – Gilead
Beyond undetectable: Aiming for long-term treatment success in people living with HIV
Chair: Alan Winston (United Kingdom)
|
Welcome and introduction Alan Winston (United Kingdom) |
12:00 -12:10 |
|
Back to “normal”: Re-initiating conversations around what success looks like in long-term management of PLWH Alan Winston (United Kingdom) |
12:10 - 12:20 |
|
Attaining long-term treatment success with B/F/TAF: What are the data telling us?
|
12:20 - 12:35 |
|
B/F/TAF in clinical practice; The added value of real-world evidence 12-month BICSTaR data
Potentially other ISR data |
12:35 - 12:50 |
|
Live Q&A with expert faculty panel
|
12:50 -13:00 |
17:30 - 19:00, room HALL S11
Industry Sponsored Session – ViiV Healthcare
The Time for Long-Acting Is Now
Chairs: Peter Reiss (The Netherlands), Jean van Wyk (United Kingdom)
|
Welcome and introduction
|
17:30 - 17:40 |
|
The key attributes – long-acting therapy Marta Boffito (United Kingdom) |
17:45 - 18:00 |
|
The evidence – efficacy, safety and patient-reported outcomes Chloe Orkin (United Kingdom) |
18:00 - 18:15 |
|
The implementation – getting started with long-acting therapy Hans Jäger (Germany) |
18:15- 18:30 |
|
Patient experience with long-acting therapy |
18:30 - 18:35 |
|
Panel discussion:
Moderators: Peter Reiss (The Netherlands) and Jean van Wyk (United Kingdom) |
18:35 - 18:50 |
|
Summary and close Peter Reiss (The Netherlands) |
18:50 - 19:00 |
12:00 - 13:30, room HALL S11
Industry Sponsored Session – ViiV Healthcare
Let’s talk about choices: putting people first
Chairs: Nneka Nwokolo (United Kingdom)
|
Welcome and introduction Nneka Nwokolo (United Kingdom) |
12:00 - 12:05 |
|
Addressing the treatment challenges of today’s HIV community
|
12:05 - 12:10 |
|
Bringing people living with HIV into the conversation
|
12:10 - 12:50 |
|
Live Q&A
|
12:50-13:05 |
|
Summary and close Nneka Nwokolo (United Kingdom) |
13:05 - 13:10 |
17:30 - 18:30, room HALL S11
Industry Sponsored Session – Gilead
Re-imagining Person-Centered HIV Care:
Clinical and System Considerations in a Pandemic Transformed World
Chairs: Anne Aslett (United Kingdom)
|
Chair’s welcome and introduction Anne Aslett (United Kingdom) |
17:30 - 17:40 |
|
Impact: How has the COVID-19 pandemic affected the cascade of care and health system supports for people impacted by HIV?
Directed Questions: Jane Anderson and Douglas Brooks |
17:40 - 18:55 |
|
Looking to the future: What have we learned and how can we modify our work to improve outcomes for all?
Directed Questions: Nikos Dedes |
17:55 -18:15 |
|
Live Q&A
|
18:15- 18:25 |
|
Session close Anne Aslett (United Kingdom) |
18:25 -18:30 |
